| Coagulopathy in COVID-19: Manifestations and management C MOC Cleveland Clinic journal of medicine 87 (8), 461, 2020 | 126 | 2020 |
| Sedation, analgesia, and paralysis in COVID-19 patients in the setting of drug shortages MA Ammar, GL Sacha, SC Welch, SN Bass, SL Kane-Gill, A Duggal, ... Journal of intensive care medicine 36 (2), 157-174, 2021 | 109 | 2021 |
| Predictors of response to fixed-dose vasopressin in adult patients with septic shock GL Sacha, SW Lam, A Duggal, H Torbic, SN Bass, SC Welch, RS Butler, ... Annals of Intensive Care 8, 1-10, 2018 | 60 | 2018 |
| Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock GL Sacha, SW Lam, L Wang, A Duggal, AJ Reddy, SR Bauer Critical care medicine 50 (4), 614-623, 2021 | 41 | 2021 |
| Vasoactive agent use in septic shock: beyond first‐line recommendations GL Sacha, SR Bauer, I Lat Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (3 …, 2019 | 29 | 2019 |
| Hypotension risk based on vasoactive agent discontinuation order in patients in the recovery phase of septic shock GL Sacha, SW Lam, A Duggal, H Torbic, AJ Reddy, SR Bauer Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (3 …, 2018 | 26 | 2018 |
| The use of gabapentin for pain and agitation in neonates and infants in a neonatal ICU GL Sacha, MG Foreman, K Kyllonen, RJ Rodriguez The Journal of Pediatric Pharmacology and Therapeutics 22 (3), 207-211, 2017 | 26 | 2017 |
| Practical aspects of targeting IL-6 in COVID-19 disease. C Calabrese, P Rajendram, GL Sacha, L Calabrese Cleveland Clinic Journal of Medicine, 2020 | 24 | 2020 |
| A multicenter, prospective, observational study to determine predictive factors for multidrug‐resistant pneumonia in critically ill adults: The DEFINE study I Lat, MJ Daley, A Shewale, MH Pangrazzi, D Hammond, KM Olsen, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (3 …, 2019 | 24 | 2019 |
| Vasodilatory shock in the ICU and the role of angiotensin II BJ Wakefield, GL Sacha, AK Khanna Current Opinion in Critical Care 24 (4), 277-285, 2018 | 23 | 2018 |
| Effects of norepinephrine and vasopressin discontinuation order in the recovery phase of septic shock: a systematic review and individual patient data meta‐analysis DA Hammond, GL Sacha, BD Bissell, N Musallam, D Altshuler, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (5 …, 2019 | 19 | 2019 |
| Safe use of vasopressin and angiotensin II for patients with circulatory shock SR Bauer, GL Sacha, SW Lam Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (8 …, 2018 | 17 | 2018 |
| Tocilizumab in coronavirus disease 2019-related critical illness: a propensity matched analysis P Rajendram, GL Sacha, O Mehkri, X Wang, X Han, V Vachharajani, ... Critical care explorations 3 (1), 2021 | 16 | 2021 |
| Timing of vasoactive agents and corticosteroid initiation in septic shock MA Ammar, AA Ammar, PM Wieruszewski, BD Bissell, M T. Long, L Albert, ... Annals of Intensive Care 12 (1), 47, 2022 | 15 | 2022 |
| The use of anti-factor Xa monitoring in a selection of patients receiving enoxaparin at a large academic medical center GL Sacha, KM Greenlee, JM Ketz Journal of thrombosis and thrombolysis 42, 479-485, 2016 | 15 | 2016 |
| Impact of pharmacists to improve patient care in the critically ill: a large multicenter analysis using meaningful metrics with the Medication Regimen Complexity-ICU (MRC-ICU … A Sikora, D Ayyala, MA Rech, SB Blackwell, J Campbell, MM Caylor, ... Critical care medicine 50 (9), 1318-1328, 2022 | 13 | 2022 |
| Association between vasopressin rebranding and utilization in patients with septic shock GL Sacha, TH Kiser, GC Wright, RW Vandivier, M Moss, EL Burnham, ... Critical Care Medicine 50 (4), 644-654, 2021 | 12 | 2021 |
| Mortality, morbidity, and costs after implementation of a vasopressin guideline in medical intensive care patients with septic shock: an interrupted time series analysis SR Bauer, GL Sacha, AJ Reddy Annals of Pharmacotherapy 54 (4), 314-321, 2020 | 11 | 2020 |
| Vasopressin plasma concentrations are not associated with hemodynamic response to exogenous vasopressin for septic shock JR Yerke, GL Sacha, RG Scheraga, DA Culver, S Abraham, H Torbic, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (1 …, 2020 | 11 | 2020 |
| Effect of phenylephrine push before continuous infusion norepinephrine in patients with septic shock JM Hawn, SR Bauer, J Yerke, M Li, X Wang, AJ Reddy, ... Chest 159 (5), 1875-1883, 2021 | 10 | 2021 |
Seth BauerMedical ICU Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic在 ccf.org 的电子邮件经过验证
Seth BauerMedical ICU Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic在 ccf.org 的电子邮件经过验证
Abhijit DuggalStaff Intensivist, Cleveland Clinic在 ccf.org 的电子邮件经过验证